CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale EVP & Chief Financial Officer sold 62,818 shares at an average $10.10 ($634,252)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes VP Operations gave up 286 shares (to pay taxes)
- 4 Shares withheld for taxes VP Peripheral Nerve Science gave up 187 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Strategy and BD Officer gave up 327 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 649 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Human Resources Officer gave up 286 shares (to pay taxes)
- 4 Shares withheld for taxes Chief R&D Officer gave up 286 shares (to pay taxes)
- 4 Option exercise CEO acquired 4,400 shares (option exercise)
- 4 Shares withheld for taxes VP Peripheral Nerve Science gave up 10,784 shares (to pay taxes)
- 4 Option exercise CEO acquired 26,746 shares (option exercise)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 8,930 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP & Chief Financial Officer sold 10,649 shares at $11.88 ($126,510)
- 4 Open-market sale Director sold 13,000 shares at $12.74 ($165,620)
- 4 Open-market sale Director sold 13,000 shares at $12.50 ($162,500)
- 10-Q Report Quarterly Report
Page 17 of 69 · 1,369 filings